marketcaparena
Search

    CPHI

    CHINA PHARMA HOLDINGS, INC.

    Company overview

    Market capitalization
    $30.76M
    Employees
    215
    Latest publication
    2026-09-29
    About CHINA PHARMA HOLDINGS, INC.

    China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection for edema diseases, hypertension, acute renal failure, hyperkalemia, hypercalcemia, and acute drug poisoning; and Candesartan for hypertension. It offers Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and Pseudophedrine Hydrochlorida sustained release tablets, as well as Hepatocyte growth-promoting factors, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. In addition, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection for nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It supplies its products to hospitals and OTC pharmacies through provincial and municipal pharmaceutical logistics companies. The company is based in Haikou, the People's Republic of China.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue948,340USD983,536USD1,225,997USD756,217USD1,025,767USD1,136,287USD1,133,995USD1,100,152USD
    Cost Of Revenue864,774USD1,523,331USD1,075,222USD815,871USD1,112,777USD1,272,348USD1,189,662USD1,619,801USD
    Gross Profit83,566USD-539,795USD150,775USD-59,654USD-87,010USD-136,061USD-55,667USD-519,649USD
    Research Development19,135USD83,762USD190,041USD40,321USD20,952USD29,587USD547USD87,610USD
    Selling General Administrative1,376,974USD1,078,616USD1,187,958USD424,827USD440,834USD594,293USD859,373USD345,051USD
    General And Administrative Expenses1,376,974USD———————
    Total Operating Expenses1,515,411USD577,469USD2,426,759USD568,491USD565,110USD1,894,905USD1,140,369USD565,608USD
    Operating Income-1,431,845USD-1,117,264USD-1,200,762USD-628,145USD-652,120USD-758,618USD-1,196,036USD-1,085,257USD
    Total Other Income Expense Net-26,278USD-25,884USD—-23,337USD123,753USD—-28,396USD-32,654USD
    Interest Income81USD147USD213USD294USD422USD1,074USD1,335USD1,460USD
    Interest Expense26,359USD26,031USD22,604USD24,046USD27,359USD28,028USD29,731USD34,114USD
    Income Before Tax-1,458,123USD-1,143,148USD-1,222,135USD-651,482USD-528,367USD-785,572USD-1,224,432USD-1,117,911USD
    Income Tax Expense0USD—————733,798USD-1,117,909,882,089USD
    Net Income-1,458,123USD-1,143,148USD-1,222,135USD-651,482USD-528,367USD-785,572USD-1,224,432USD-1,117,911USD
    Selling And Marketing Expenses—109,342USD—78,041USD101,292USD—174,579USD134,603USD
    Net Interest Income—-25,884USD-22,391USD-23,752USD-26,937USD-26,954USD-28,396USD-32,654USD
    Tax Provision—0USD0USD0USD0USD0USD0USD0USD
    Net Income From Continuing Ops—-1,143,148USD-1,222,135USD-651,482USD-528,367USD-785,572USD-1,224,432USD-1,117,911USD
    Ebit—-1,117,264USD—-627,436USD-501,008USD—-1,194,701USD-1,083,797USD
    Ebitda—-136,694USD—-271,402USD-180,145USD—-746,628USD-386,853USD
    Depreciation And Amortization—980,570USD—356,034USD320,863USD—448,073USD696,944USD
    Reconciled Depreciation—980,570USD572,959USD356,034USD320,863USD329,313USD448,073USD696,943USD
    Unclassified Operating Expenses——1,048,760USD——1,271,025USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue4,144,268USD4,528,929USD7,011,299USD8,104,092USD9,641,925USD10,866,449USD10,923,936USD12,330,687USD
    Cost Of Revenue4,276,218USD6,514,577USD7,292,384USD8,598,008USD9,292,655USD8,913,543USD9,441,752USD10,355,839USD
    Gross Profit-131,950USD-1,985,648USD-281,085USD-493,916USD349,270USD1,952,906USD1,482,184USD1,974,848USD
    Research Development280,901USD283,942USD240,080USD185,858USD318,964USD377,964USD229,637USD172,384USD
    Selling General Administrative2,451,459USD1,784,750USD1,466,084USD1,893,269USD1,651,024USD1,822,655USD2,289,520USD1,949,921USD
    Selling And Marketing Expenses375,786USD528,824USD780,328USD1,069,785USD1,495,007USD2,215,394USD2,352,610USD—
    Total Operating Expenses2,956,590USD2,603,218USD2,470,735USD3,055,061USD3,209,780USD4,531,199USD4,871,767USD-12,422,262USD
    Operating Income-3,088,540USD-4,588,866USD-2,751,820USD-3,548,977USD-2,860,510USD-2,578,293USD-3,389,583USD-3,968,357USD
    Interest Income2,003USD6,641USD5,075USD10,755USD3,035USD5,675USD27,527USD38,516USD
    Interest Expense102,037USD154,140USD333,600USD434,619USD542,000USD294,159USD321,718USD451,258USD
    Net Interest Income-100,034USD-147,499USD-374,448USD-423,864USD-538,966USD-288,484USD-294,191USD-412,742USD
    Income Before Tax-3,187,556USD-4,736,365USD-3,078,818USD-3,972,841USD-3,399,476USD-2,866,777USD-20,702,044USD-10,860,156USD
    Tax Provision0USD0USD0USD0USD0USD0USD0USD-109,989USD
    Net Income-3,187,556USD-4,736,365USD-3,078,818USD-3,972,841USD-3,399,476USD-2,866,777USD-20,702,044USD-10,750,167USD
    Net Income From Continuing Ops-3,187,556USD-4,736,365USD-3,110,789USD-3,972,841USD-3,399,476USD-2,866,777USD-20,702,044USD-10,750,167USD
    Ebit-3,085,519USD-4,582,225USD-2,745,218USD-3,538,222USD-2,857,475USD-2,572,618USD-20,380,326USD-10,408,898USD
    Ebitda-1,506,350USD-1,964,159USD8,436USD-837,689USD230,345USD106,852USD-17,451,527USD-7,150,159USD
    Depreciation And Amortization1,579,169USD2,618,066USD2,753,654USD2,700,533USD3,087,820USD2,679,470USD2,928,799USD3,258,739USD
    Reconciled Depreciation1,579,169USD2,618,066USD2,697,243USD2,700,533USD3,087,820USD2,679,470USD2,928,799USD3,258,739USD
    Total Other Income Expense Net-99,016USD-147,499USD-326,998USD-423,864USD-538,966USD-288,484USD-17,309,308USD-6,891,799USD
    Income Tax Expense—-4,736,360,263,635USD-4USD6,248,794USD542,000USD294,159USD321,718USD-109,989USD
    Net Income Applicable To Common Shares————-3,399,476USD-2,866,777USD-20,702,044USD-10,750,167USD
    Non Operating Income Net Other—————5,675USD27,527USD38,516USD
    Unclassified Operating Expenses———————-14,544,567USD
    Minority Interest———————0USD
    Discontinued Operations———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets44,709,903USD45,323,790USD30,999,464USD15,984,793USD13,766,560USD14,217,073USD14,887,524USD13,465,610USD
    Cash And Equivalents304,874USD———————
    Total Current Assets2,006,618USD2,003,555USD2,346,407USD2,329,427USD2,700,791USD2,850,876USD3,270,389USD3,738,977USD
    Total Liabilities8,528,623USD———————
    Total Current Liabilities7,681,602USD7,267,678USD7,400,359USD6,622,806USD5,250,655USD5,121,877USD5,017,288USD4,760,209USD
    Other Current Liabilities500,160USD———————
    Total Stockholder Equity36,181,280USD37,204,190USD22,739,752USD8,493,997USD6,461,744USD6,969,848USD7,747,904USD6,528,249USD
    Total Equity Including Noncontrolling Interest36,181,280USD———————
    Deferred Revenue153,642USD———————
    Net Receivables181,621USD257,919USD241,412USD285,913USD317,154USD367,947USD281,068USD406,867USD
    Inventory1,362,423USD1,502,883USD1,621,423USD1,673,565USD1,678,769USD1,978,918USD2,266,154USD2,498,851USD
    Property Plant Equipment Net4,365,944USD4,465,868USD4,173,058USD4,700,330USD4,232,440USD4,403,883USD4,529,863USD4,962,683USD
    Intangible Assets38,337,341USD38,674,367USD24,479,999USD8,775,036USD6,833,329USD6,962,314USD7,087,272USD4,763,950USD
    Accounts Payable734,042USD837,108USD891,083USD588,739USD530,729USD548,257USD225,106USD390,239USD
    Short Term Debt73,069USD3,466,347USD—3,439,546USD2,106,068USD2,113,273USD2,199,833USD2,583,719USD
    Common Stock40,522USD40,522USD—5,022USD3,262USD3,262USD32,618USD17,859USD
    Retained Earnings-49,815,506USD-48,357,383USD-47,214,235USD-45,992,100USD-45,340,618USD-44,812,251USD-44,026,679USD-42,802,247USD
    Accumulated Other Comprehensive Income12,631,445USD12,016,232USD—11,404,756USD11,347,421USD11,327,158USD11,319,642USD11,522,615USD
    Other Current Assets—74,279USD—75,627USD79,836USD91,323USD96,288USD114,568USD
    Total Liab—8,119,600USD8,259,712USD7,490,796USD7,304,816USD7,247,225USD7,139,620USD6,937,361USD
    Other Current Liab—2,902,477USD—2,473,609USD1,794,799USD2,345,912USD1,834,665USD1,362,119USD
    Capital Stock—40,522USD15,522USD5,022USD3,262USD3,262USD32,618USD17,859USD
    Cash—168,474USD345,112USD267,625USD625,032USD412,688USD626,879USD718,691USD
    Cash And Short Term Investments—168,474USD—294,322USD625,032USD412,688USD626,879USD718,691USD
    Current Deferred Revenue—61,746USD—120,912USD77,683USD114,435USD162,208USD24,920USD
    Net Debt—3,390,167USD3,358,903USD3,300,178USD2,800,951USD3,093,692USD2,964,084USD3,292,091USD
    Short Long Term Debt—3,692,422USD3,704,015USD3,369,220USD2,106,068USD2,093,497USD2,160,510USD2,523,478USD
    Short Long Term Debt Total—3,558,641USD—3,567,803USD3,425,983USD3,506,380USD3,590,963USD4,010,782USD
    Property Plant Equipment Gross—38,221,176USD37,662,909USD37,274,065USD36,800,745USD36,719,436USD36,628,259USD37,574,109USD
    Common Stock Shares Outstanding—4,291,000shares15,522,002shares3,874,000shares3,262,000shares4,259,428shares4,758,142shares4,758,142shares
    Non Current Assets Total—43,320,235USD28,653,057USD13,655,366USD11,065,769USD11,366,197USD11,617,135USD9,726,633USD
    Non Current Liabilities Total—851,922USD859,353USD867,989USD2,054,161USD2,125,348USD2,122,332USD2,177,152USD
    Non Currrent Assets Other—-180,000USD—————718,690,281,309USD
    Net Working Capital—-5,264,123USD-5,053,952USD-4,293,379USD-2,549,864USD-2,271,001USD-1,746,899USD-1,021,232USD
    Unclassified Current Liabilities—-3,692,422USD2,805,261USD-3,369,220USD-1,364,692USD-2,093,497USD-1,565,034USD-2,124,266USD
    Unclassified Equity—73,464,297USD69,938,465USD43,071,297USD40,448,417USD40,448,417USD40,389,705USD37,772,163USD
    Short Term Investments———26,697USD———26,943USD
    Long Term Debt————1,319,915USD1,393,107USD1,391,130USD1,427,063USD
    Good Will———————401,957USD
    Other Assets———————13,465,596,534,390USD
    Unclassified Non Current Assets———————-14,184,287,217,656USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets30,999,464USD14,887,524USD16,469,200USD17,784,143USD22,649,767USD21,117,991USD22,235,222USD45,377,325USD
    Intangible Assets24,079,265,000,000USD7,087,272USD3,652,916USD2,211,913USD589,624USD613,827USD609,366USD676,055USD
    Other Current Assets379,871,709,327USD96,288USD112,271USD522,334USD59,263USD129,642USD233,188USD1,397,746USD
    Total Liab8,259,712USD7,139,620USD9,014,579USD13,494,145USD16,631,886USD13,113,460USD12,997,621USD15,178,550USD
    Total Stockholder Equity22,739,752USD7,747,904USD7,454,621USD4,289,998USD6,017,881USD8,004,531USD9,237,601USD30,198,775USD
    Other Current Liab7,328,730,037,289USD1,834,665USD1,554,335USD1,728,891USD1,340,991USD2,925,567USD3,750,212USD5,009,575USD
    Common Stock155,220USD32,618USD10,625USD74,909USD47,340USD45,580USD43,580USD43,580USD
    Capital Stock15,522USD32,618USD10,625USD74,909USD47,340USD45,580USD43,580USD43,580USD
    Retained Earnings-47,214,235USD-44,026,679USD-39,290,314USD-36,211,496USD-32,238,655USD-28,839,179USD-25,972,402USD-5,270,358USD
    Cash3,451,120USD626,879USD1,423,838USD2,029,971USD4,859,059USD957,653USD1,074,979USD1,186,587USD
    Cash And Short Term Investments3,451,120USD626,879USD1,423,838USD2,029,971USD4,859,059USD957,653USD1,074,979USD1,186,587USD
    Total Current Assets23,464,070USD3,270,389USD5,996,933USD5,964,546USD9,093,409USD5,321,958USD5,579,005USD8,746,916USD
    Total Current Liabilities7,400,359USD5,017,288USD6,820,664USD12,739,447USD10,513,298USD11,403,676USD10,045,308USD10,051,456USD
    Net Debt-16,193,600USD2,964,084USD3,210,179USD6,727,229USD7,629,030USD6,470,304USD5,547,258USD6,631,433USD
    Short Term Debt7,234,428USD2,199,833USD3,182,216USD8,757,200USD7,193,908USD6,523,729USD4,423,368USD3,455,300USD
    Short Long Term Debt3,704,015USD2,160,510USD3,104,489USD8,716,755USD7,108,626USD6,471,659USD2,260,076USD3,455,300USD
    Short Long Term Debt Total18,317,600USD3,590,963USD4,634,017USD8,757,200USD12,488,089USD7,427,957USD6,622,237USD7,818,020USD
    Net Receivables290,673USD281,068USD728,307USD464,454USD835,401USD529,544USD682,014USD1,087,029USD
    Inventory1,621,423USD2,266,154USD3,732,517USD2,947,787USD3,339,686USD3,705,119USD3,588,824USD5,054,975USD
    Accounts Payable891,083USD225,106USD966,420USD667,082USD926,749USD1,234,594USD1,366,330USD1,060,934USD
    Property Plant Equipment Net4,573,792USD4,529,863USD6,819,351USD9,607,684USD12,966,734USD15,182,206USD16,046,851USD18,884,767USD
    Property Plant Equipment Gross37,662,909USD36,628,259USD37,214,006USD37,958,049USD41,125,345USD15,182,206USD16,046,851USD18,884,767USD
    Accumulated Other Comprehensive Income11,582,646USD11,319,642USD11,452,054USD11,573,065USD12,563,829USD12,345,446USD11,576,219USD11,835,349USD
    Common Stock Shares Outstanding4,291,000shares17,463,723shares10,599,432shares5,256,855shares4,612,926shares4,612,930shares4,612,930shares4,612,930shares
    Non Current Assets Total28,653,057USD11,617,135USD10,472,267USD11,819,597USD13,556,358USD15,796,033USD16,656,217USD36,630,409USD
    Non Current Liabilities Total8,593,530USD2,122,332USD2,193,915USD754,698USD6,118,588USD1,709,784USD2,952,313USD5,127,094USD
    Non Currrent Assets Other-180,000USD391,836USD-397,684USD-11,819,597USD-13,556,358USD-15,796,033USD-16,656,217USD17,069,587USD
    Net Working Capital-5,053,952USD-1,746,899USD-823,731USD-6,774,901USD-1,419,889USD-6,081,718USD-4,466,303USD-1,304,540USD
    Unclassified Current Assets-379,853,608,473USD-626,878,373,121USD——————
    Unclassified Non Current Assets-24,079,240,920,735USD——————-17,069,587USD
    Unclassified Current Liabilities-7,328,734,466,456USD-1,565,034USD-2,077,303USD-7,650,776USD-6,267,004USD-6,471,659USD-2,260,076USD-3,455,300USD
    Unclassified Non Current Liabilities8,593,530USD———————
    Unclassified Equity58,200,599USD40,389,705USD35,271,631USD28,778,611USD25,598,027USD24,407,104USD23,546,624USD23,546,624USD
    Good Will—-391,836USD397,684USD————0USD
    Other Assets—-3,270,385,549,611USD———49,687USD—17,069,587USD
    Current Deferred Revenue—162,208USD90,507USD520,295USD210,028USD719,786USD505,398USD525,647USD
    Long Term Debt—1,391,130USD1,411,891USD—5,250,000USD904,228USD2,150,168USD4,362,720USD
    Short Term Investments—626,878,373,121USD65,915USD13,784USD91,362USD53,736USD45,756USD20,579USD
    Other Liab————824,407USD805,556USD753,444USD764,374USD
    Net Tangible Assets————5,870,040USD7,822,385USD9,031,990USD29,932,332USD
    Deferred Long Term Liab—————805,556USD753,444USD764,374USD
    Non Current Liabilities Other——————48,701USD0USD
    Long Term Investments———————0USD
    Accumulated Depreciation———————0USD
    Additional Paid In Capital———————0USD
    Treasury Stock———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation2,082,425USD
    Stock Based Compensation0USD
    Change To Inventory520,421USD
    Change In Working Capital520,421USD
    Operating Cash Flow-88,120USD
    Net Debt Issuance-79,000USD
    Unclassified Financing Cash Flow119,793USD
    Financing Cash Flow40,793USD
    Effect Of Forex Changes On Cash7,089USD
    Change In Cash-40,238USD
    End Cash Flow304,874USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-1,143,148USD-1,222,135USD-651,482USD-528,367USD-785,572USD-1,224,432USD-1,117,911USD-1,438,130USD
    Depreciation980,570USD572,959USD356,034USD320,863USD329,313USD448,073USD696,943USD739,252USD
    Other Non Cash Items-1,435USD—109,249USD211,585USD212,056USD-12,298USD50,897USD293,649USD
    Change To Account Receivables-14,019USD—-117,491USD-20,566USD-164,670USD-212,942USD-167,299USD62,163USD
    Change To Inventory247,492USD210,551USD57,779USD164,804USD156,627USD510,996USD376,771USD581,031USD
    Change In Working Capital108,721USD14,447,329USD-50,788USD286,999USD186,381USD1,027,131USD323,119USD332,503USD
    Total Cash From Operating Activities-55,292USD151,990USD-236,987USD291,080USD-57,822USD238,474USD-46,952USD-72,726USD
    Capital Expenditures-5,767USD-5,767USD-613USD-9,921USD-80,965USD-272,852USD-9,220USD-28,086USD
    Free Cash Flow-55,290USD146,223USD-237,600USD281,159USD-138,787USD-34,378USD-37,732USD-100,812USD
    Total Cashflows From Investing Activities-5,767USD—-40,598USD-9,921USD-80,965USD-272,852USD9,220USD-28,086USD
    Net Borrowings-79,325USD-72,592USD-122,214USD-22,401USD-76,820USD6,802USD6,843USD—
    Total Cash From Financing Activities-79,325USD-72,592USD-122,214USD-29,188USD-70,033USD6,802USD6,843USD6,852USD
    Change In Cash-176,638USD77,487USD-357,407USD212,344USD-214,191USD-91,812USD-20,646USD-99,544USD
    Begin Period Cash Flow345,112USD267,625USD625,032USD412,688USD626,879USD718,691USD739,337USD838,881USD
    End Period Cash Flow168,474USD345,112USD267,625USD625,032USD412,688USD626,879USD718,691USD739,337USD
    Other Cashflows From Investing Activities-5,313USD—-72,613,967,000USD-9,986USD-22,641USD-253,307USD—-28,086USD
    Other Cashflows From Financing Activities-79,325,000,000USD—-221,434,901,000USD-6,787USD6,787USD—6,843USD-6,856USD
    Unclassified Financing Cash Flow79,325,000,000USD—221,434,901,000USD—————
    Unclassified Operating Cash Flow—-13,646,163USD——————
    Investments——-40,598USD-9,921USD-80,965USD-272,852USD9,220USD-28,086USD
    Unclassified Investing Cash Flow——72,613,967,613USD—————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-3,187,556USD-4,736,365USD-3,078,818USD-3,972,841USD-3,399,476USD-2,866,777USD-20,702,044USD-10,750,167USD
    Depreciation1,579,169USD2,618,066USD2,753,653USD2,700,533USD3,087,820USD2,679,470USD2,928,799USD3,258,739USD
    Other Non Cash Items-13,113,273USD456,440USD21,654USD-93,851USD-5,215USD115,186USD17,271,735USD8,037,756USD
    Change To Account Receivables13,208,415USD-197,708USD-938,021USD-170,194USD-545,534USD-733,452USD-1,201,461USD99,400USD
    Change To Inventory589,761USD1,606,888USD-17,058USD689,104USD1,011,905USD807,592USD1,999,978USD688,852USD
    Change In Working Capital14,869,921USD1,195,497USD-396,175USD878,344USD51,790USD29,861USD1,109,822USD642,245USD
    Total Cash From Operating Activities148,261USD-466,362USD-699,686USD-409,545USD-249,838USD-42,260USD608,312USD1,256,992USD
    Capital Expenditures-137,251USD-291,718USD-11,517USD-401,964USD-438,055USD-867,307USD-136,003USD-51,145USD
    Free Cash Flow11,010USD-758,080USD-711,203USD-811,509USD-687,893USD-909,567USD472,309USD1,205,847USD
    Total Cashflows From Investing Activities-137,251USD-291,718USD-11,517USD-401,964USD-438,055USD-867,307USD-136,003USD-51,145USD
    Net Borrowings-294,027USD27,353USD73,145USD-1,546,994USD4,597,738USD624,177USD445,629USD287,423USD
    Total Cash From Financing Activities-294,027USD27,353USD73,145USD-1,770,007USD4,597,738USD624,177USD-1,728,770USD-1,976,454USD
    Change In Cash-281,767USD-796,959USD-606,133USD-2,829,088USD3,901,406USD-227,234USD-1,275,640USD-843,627USD
    Begin Period Cash Flow626,879USD1,423,838USD2,029,971USD4,859,059USD957,653USD1,184,887USD2,460,527USD2,030,214USD
    End Period Cash Flow345,112USD626,879USD1,423,838USD2,029,971USD4,859,059USD957,653USD1,184,887USD1,186,587USD
    Other Cashflows From Investing Activities-77,927USD-253,307USD—————0USD
    Other Cashflows From Financing Activities-294,027,000,000USD27,352,972,647USD-11,517USD-223,013USD-438,055USD-867,307USD691,459USD287,423USD
    Unclassified Financing Cash Flow294,027,000,000USD-27,352,972,647USD————-2,865,858USD-2,551,300USD
    Investments—-291,718USD20,278USD-401,964USD-438,055USD-867,307USD-136,003USD-51,145USD
    Stock Based Compensation——0USD78,270USD15,243USD0USD——
    Change To Liabilities————-853,193USD-44,279USD-456,252USD249,234USD
    Exchange Rate Changes—————58,156USD-19,179USD-73,020USD
    Cash And Cash Equivalents Changes—————-227,234USD-1,275,640USD-843,627USD
    Dividends Paid———————0USD
    Sale Purchase Of Stock———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2020Yearly · 2020-12-31SegmentCOVID19Testers1,734,233USD0001213900-22-016151
    FY 2020Yearly · 2020-12-31SegmentDomestic Pharmaceuticals9,132,216USD0001213900-22-016151
    Q2 2020Quarterly · 2020-06-30SegmentCOVID19Testers1,701,108USD0001213900-21-042474
    Q2 2020Quarterly · 2020-06-30SegmentDomestic Pharmaceuticals2,069,615USD0001213900-21-042474

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.